fashion -WSS

fashion

author：explore 2025-10-02 22:24:28 - browse：84

Senate Health, Education, Labor, and Pensions Committee Chairman Bernie Sanders looks at Moderna CEO Stephane Bancel as he testifies. Sitting next to Sanders, ranking member Sen. Bill Cassidy looks down – policy coverage from STAT — Committee Ranking Republican Bill Cassidy (La.) and Chairman Bernie Sanders (I-Vt.) Chip Somodevilla/Getty Images

WASHINGTON – The Senate health committee on Thursday passed a package of bills aimed at speeding generic drug competition and reining in drug middlemen business practices. But they failed to pass an ambitious reform to the pharmacy benefit manager sector, despite strong bipartisan support for it.

Chairman Bernie Sanders (I-Vt.) is pursuing the drug pricing reforms at the behest of Senate Majority Leader Chuck Schumer (D-N.Y.), who wants to hold a floor vote on an even bigger package of health bills later this year. The markup came just a day after the same panel held a major hearing on PBM and drugmakers’ role in high insulin prices.

It’s not clear when the Senate would take up that package, and while the package is bipartisan, it’s not clear whether it has enough support among House Republicans to pass in that chamber. There are a few, tamer PBM bills that the House Energy and Commerce Committee is expected to mark up May 17, but there is no indication that Senate and House lawmakers are coordinating on PBM legislation.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical records are filled with copy
Next article： Profiling embryos to choose those with higher IQs is almost a reality

explore

Wikipedia

WSS

Boston Scientific acquires urology company Axonics for $3.7 billion

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

At JPM 2024, hospital systems pitch financial strength to investors

Stories you might have missed in 2023: health, science, medicine

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

Boston Scientific acquires urology company Axonics for $3.7 billion

leisure time

fashion

explore

New air purifier tech could be key to improving indoor air quality

Xenotransplantation trials will require adjusting expectations, experts say

In age of alternative facts, a scholarly course on calling out crap

Arena BioWorks launches in Cambridge to speed drug discovery

BioMarin wins approval for gene therapy to treat hemophilia A

Profiling embryos to choose those with higher IQs is almost a reality

Guidelines to prevent youth baseball injuries need more muscle

Does Paxlovid work in people vaccinated against Covid

Heart attack and stroke risk calculators need revising

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

focus

Allen Institute goes after foundational questions, CEO Costa says

A public health expert passes on football's full body collisions for youths

Mom launches Girl Scout troop for LGBTQ youth in Texas

The thinking behind the controversial eating disorder chatbot Tessa

Boston Scientific acquires urology company Axonics for $3.7 billion

Biogen nominates mother of director’s child to replace him on board

explore

Wikipedia

entertainment

entertainment